Upstate Active Clinical Trials

Study Title:

GOG 0258:A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma

What is the purpose of the study?

This randomized phase III trial studies carboplatin and paclitaxel to see how well they work with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer. Drugs used in chemotherapy, such as carboplatin, paclitaxel, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Giving chemotherapy and radiation therapy after surgery may kill any tumor cells that remain after surgery. It is not yet known whether carboplatin and paclitaxel are more effective with or without cisplatin and radiation therapy in treating patients with endometrial cancer.

Upstate Institutional Review Board (IRB) Number:

227415

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

ClinicalTrials.Gov ID:

NCT00942357

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Elizabeth Anderson
Phone: 315-470-2620
Email: anderse@upstate.edu

Return to Previous Page || Search Again